MI
PEARW

MMCAP International’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

MMCAP International’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-33,333
Closed -$32K – 490
2021
Q3 		$32K Hold
33,333
– – ﹤0.01% 402
2021
Q2 		$49K Buy
+33,333
New +$29.1K ﹤0.01% 382

Other funds holding PEARW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $1B AUM 50.12% 1-Year Est. Return

MMCAP International's PEARW Position: Q4 2021 in Review

MMCAP International sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q4 2021, closing a stake of 33,333 shares — an estimated $32K sold.

MMCAP International first reported a position in PEARW in Q2 2021 and held it in 2 quarters. The position peaked at $49K in Q2 2021. 44 funds tracked by Wall St. Rank hold PEARW as of Q4 2021.

  • MMCAP International reported no remaining Pear Therapeutics, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • MMCAP International sold 33,333 Pear Therapeutics, Inc. Warrant shares in Q4 2021, an estimated $32K.
  • MMCAP International first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 2 quarters.
  • MMCAP International's Pear Therapeutics, Inc. Warrant position peaked at $49K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q4 2021.

Based on MMCAP International's 13F filing for Q4 2021, filed 9 Feb 2022.